0001127602-20-020691.txt : 20200701 0001127602-20-020691.hdr.sgml : 20200701 20200701200050 ACCESSION NUMBER: 0001127602-20-020691 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200624 FILED AS OF DATE: 20200701 DATE AS OF CHANGE: 20200701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grygiel Nancy A. CENTRAL INDEX KEY: 0001816414 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37702 FILM NUMBER: 201006698 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 3 1 form3.xml PRIMARY DOCUMENT X0206 3 2020-06-24 0 0000318154 AMGEN INC AMGN 0001816414 Grygiel Nancy A. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 1 SVP & CCO Common Stock 3142 D Common Stock 88.786 I 401(k) Plan Nqso (Right to Buy) 162.60 2019-05-01 2027-05-01 Common Stock 4139 D Nqso (Right to Buy) 177.46 2020-04-27 2028-04-27 Common Stock 3470 D Nqso (Right to Buy) 177.31 2021-05-03 2029-05-03 Common Stock 3948 D Nqso (Right to Buy) 236.36 2022-05-05 2030-05-05 Common Stock 3542 D These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 748 RSUs which fully vest on 8/1/2020; 159 RSUs which fully vest on 5/1/2021; 302 RSUs which vest in two installments of 149 on 4/27/2021 and 153 on 4/27/2022; 452 RSUs which vest in two installments of 149 on 5/3/2021 and 5/3/2022 and one installment of 154 on 5/3/2023; and 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 142 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. 2,731 of these non-qualified stock options have vested and are exercisable and 1,408 of these options will vest and become exercisable on 5/1/2021. 1,145 of these non-qualified stock options have vested and are exercisable and the remaining options will vest and become exercisable in installments of 1,145 on 4/27/2021 and 1,180 on 4/27/2022. These non-qualified stock options will vest and become exercisable in three installments of 1,302 on 5/3/2021, 1,303 on 5/3/2022 and 1,343 on 5/3/2023. These non-qualified stock options will vest and become exercisable in three installments of 1,168 on 5/5/2022, 1,169 on 5/5/2023 and 1,205 on 5/5/2024. /s/ Andrea A. Robinson, Attorney-in-Fact for Ms. Grygiel 2020-06-30 EX-24 2 doc1.txt POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY Exhibit 24 Power of Attorney Know all men by these presents, that the undersigned hereby constitutes and appoints each of Dennis Yai and Andrea A. Robinson, signing singly, the undersigned's true and lawful attorney-in-fact to execute for and on behalf of the undersigned Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder, as may be required as a result of the undersigneds position as an officer and/or director of Amgen Inc. (the "Company"). The undersigned hereby grants to each such attorney-in-fact full power and authority to execute such Forms 3, 4 and 5 as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigneds holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys- in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 6th day of June, 2020. /s/ Nancy A. Grygiel Name: Nancy A. Grygiel